Patients treated with on dupilumab showed significant improvement in sustained BP remission compared with those on placebo.
The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...
New therapeutic 'cocktails' may provide long-lasting relief for treatment-resistant asthma and other immune system inflammatory diseases.
Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the ...
Millions of Brits live with asthma and rely on a variety of treatments to manage their condition, but a new study has raised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results